Back to available technologies

Search our Available Technologies

By Clinical Application > Immunology, Autoimmune & Inflammation

Inhibition of endosomal TLR-activation with nucleic acid binding polymers

Value Proposition Inflammatory and autoimmune diseases are the result of...


A novel small molecule activator of sirtuins

Value Proposition Sirtuins are a family of protein deacetylases with...


Topical MEK inhibition as a new modality for inflammatory skin diseases and cancers

Value Proposition Inflammatory skin conditions affect many people, with a...


A therapeutic formulation for preventing posttraumatic osteoarthritis after joint injuries

Value Proposition Osteoarthritis (OA) is an affliction of the joints...


Novel small molecule mast cell activator vaccine adjuvants

Value Proposition Mast cells (MCs) are innate immune cells highly...


A method for treating pain and inflammation using GPR37 agonists

Value proposition Uncontrolled inflammation is a prominent component of many...


Methods for treating pain and predicting cancer immune therapy efficacy

Value proposition Chronic pain is a major health problem that...


HS206, a selective inhibitor of Transforming growth factor β-activated kinase 1 (TAK1, MAP3K7)

Value Proposition Transforming growth factor b-activated kinase 1 (TAK1) plays...


Peptide materials for immunomodulation

Value Proposition Glatiramoids are biomaterials synthesized for use as immunomodulators....